Topic
Oncology
294 Podcasts • 75 Cases • 19 Courses on BackTable
Hear how experienced clinicians in Oncology approach day-to-day decision-making on BackTable. Learn from podcasts, cases, and courses curated by physician content creators. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 303 • 19 May 2026
PARP Inhibitors: Clinical Trials & Real-World Applications
Keeping patients on PARP inhibitors long enough to see real benefit often comes down to proactive side effect management. In this episode of BackTable Urology, Dr. Neeraj Agarwal and Dr. Arun Azad join host Dr. Alan Tan to discuss practical, evidence-based strategies for managing hematologic and GI toxicities in advanced prostate cancer patients receiving PARP inhibitors.
This podcast is supported by an educational grant from Pfizer.
More on Oncology
Loading recent podcasts…
Urology Episode #303
May 19, 2026
with Dr. Neeraj Agarwal, Dr. Arun Azad, Dr. Alan Tan
Keeping patients on PARP inhibitors long enough to see real benefit often comes down to proactive side effect...
Tumor Board Episode #59
May 12, 2026
with Dr. Jonathan Mizrahi, Dr. Lingling Du, Dr. Craig Lockhart
With new systemic and liver-directed approaches under investigation, which targets and treatment strategies are most...
VI Episode #642
May 7, 2026
with Dr. Beau Toskich, Dr. Zach Berman, Dr. Venkatesh Krishnasamy
Complete pathologic necrosis (CPN) rates above 90%? This week’s BackTable episode from the 2026 HCC Creator Weekend™ is...
20+ listens
Urology Episode #301
May 5, 2026
with Dr. Udit Singhal, Dr. Ruchika Talwar
Are biomarkers the missing link in personalized prostate cancer care? What is the practical role of biomarkers across...
870+ listens
Tumor Board Episode #60
May 19, 2026
with Dr. Neeraj Agarwal, Dr. Arun Azad, Dr. Alan Tan
Keeping patients on PARP inhibitors long enough to see real benefit often comes down to proactive side effect...
VI Episode #644
May 12, 2026
with Dr. Neil Mehta, Dr. Ari Cohen, Dr. Venkatesh Krishnasamy
A high-functioning HCC tumor board can turn complex transplant decisions into coordinated treatment plans that account...
Tumor Board Episode #58
May 5, 2026
with Dr. Craig Lockhart, Dr. Lingling Du, Dr. Jonathan Mizrahi
When first-line treatment for advanced hepatocellular carcinoma (HCC) fails and the disease progresses, what options...
70+ listens
VI Episode #641
May 5, 2026
with Dr. Neil Mehta, Dr. Riad Salem, Dr. Tyler Sandow
With recent updates to the Barcelona Clinic Liver Classification (BCLC), how should multidisciplinary teams adapt their...
1,100+ listens
VI Case
Aug 12, 2025
with Dr. Zach Berman and Dr. Christopher Beck
VI Case
Aug 12, 2025
with Dr. Zach Berman and Dr. Christopher Beck
VI Case
Aug 12, 2025
with Dr. Zach Berman and Dr. Christopher Beck
VI Case
Jul 1, 2025
with Dr. Nima Kokabi, Dr. Tyler Sandow and Dr. Venkatesh Krishnasamy
VI Case
Aug 12, 2025
with Dr. Zach Berman and Dr. Christopher Beck
VI Case
Aug 12, 2025
with Dr. Zach Berman and Dr. Christopher Beck
VI Case
Aug 12, 2025
with Dr. Zach Berman and Dr. Christopher Beck
VI Case
Jul 8, 2025
with Dr. Tyler Sandow, Dr. Zach Berman and Dr. Venkatesh Krishnasamy
Tumor Board Course
2 CME/CE credits, 2.5 hours, 26 lessons
Urology Course
3 hours, 28 lessons
Tumor Board Course
2 CME/CE credits, 2.5 hours, 19 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.